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Abstract 
Introduction: Evaluation of the quality of life of patients with osteoporosis
concerns the physical, emotional, social and pain quality of life domains. The
aim of the research was to describe the psychometric properties of the Polish
version of QUALEFFO-41 in 253 Polish postmenopausal women with osteopenia
or osteoporosis and in 132 postmenopausal women with normal BMD.
Material and methods: The internal reliability of QUALEFFO-41 was studied using
Cronbach’s alpha coefficient. The reproducibility of the QUALEFFO-41 scales was
assessed using Pearson’s correlation. The capacity of questions to discriminate
between women with reduced bone mineral density (BMD) and normal subjects
was assessed by conditional logistic regression to derive an odds ratio with 95%
confidence intervals. The discriminative power, which measures the ability of
the questionnaire to discriminate between patients, was assessed by clinical
validity. Additionally, receiver operating characteristic (ROC) curves were
constructed to assess the ability of QUALEFFO-41.
Results: Cronbach’s α coefficient reflecting the reliability and repeatability of
the instrument for all domains was satisfactory. Results of scores for domains
of QUALEFFO-41 and the score for total QUALEFFO-41 demonstrate a significant
difference (p < 0.001) among all groups; only in the case of the pain domain
was there a significant difference at the level of p < 0.01 between normal
subjects and osteoporotic patients. Receiver operating characteristic curve
analysis demonstrated a good discriminating capacity of individual domains and
total QUALEFFO-41 score.
Conclusions: The Polish version of QUALEFFO-41 can be used among patients
with reduced BMD compared to normal subjects, independently of vertebral
fractures, as it is coherent and discriminates well between women with reduced
BMD and normal subjects.
Key words: QUALEFFO-41, quality of life, vertebral fracture, psychometric properties,
postmenopausal women.
Introduction
A consequence of reduced bone mineral density (BMD) is osteoporosis,
which constitutes a problem not only for patients with osteoporosis but
also for their families and society as a whole [1-3].
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The principal goals of health care for post  meno  -
pausal women with reduced BMD are: to prevent
fractures, to minimize functional loss, maintain
independence, and preserve quality of life (QoL). In
the past two decades, health status instruments
for assessment of quality of life have proven to be
valuable, relevant outcome measures in both clinical
trials and clinical practice [4]. Questionnaires based
on health status variables, such as mobility, mood,
and social function, are particularly relevant
because they assess the aspects of outcome that
most concern the individual patient [5]. Generic
health status instruments can be used to compare
patients with different diseases. Several generic
instruments for measuring QoL have been
developed, for example the Nottingham Health
Profile (NHP) [6], the Sickness Impact Profile (SIP)
[7], the Short Form 36 of the Medical Outcomes
Study (SF-36) [8], the EuroQoL (EQ-5D) [9], or the
World Health Organization Quality of Life 100 and
BREF (WHOQOL 100 and BREF) [10]. 
Since important areas for specific patient groups
may be omitted, disease-specific instruments have
also appeared for patients with osteoporosis [11-
17]. Among them, there is the Quality of Life
Questionnaire of the European Foundation for
Osteoporosis (QUALEFFO 41) [18]. The 41 questions
are grouped in the following five domains: pain,
physical function (activities of daily living, jobs
around the house and mobility), social function,
general health perception and mental function. The
QUALEFFO-41 questionnaire has been translated
from English into many languages, including into
Polish. 
We chose QUALEFFO-41 for our study because
this questionnaire has been the most widely used
in European studies.
The QUALEFFO-41 scale is used generally for
osteoporosis patients with vertebral fractures.
However, in clinical trials it can be found that this
scale is also used in osteoporosis patients without
vertebral fractures, especially when BMD mea  -
surements were made in the lumbar spine. We
were interested whether the Polish version of
QUALEFFO-41 is able to distinguish patients with
reduced BMD from normal subjects, independently
of vertebral fractures. 
Therefore our study aimed to describe the
psychometric properties of the Polish version of
QUALEFFO-41 in relation to score construction,
reliability, and validity among postmenopausal
women with reduced BMD, independently of
vertebral fractures.
In addition, the study was to assess the quality
of life among  postmenopausal women with
reduced BMD and compare the quality of life
among women with and without vertebral
deformities.
Material and methods
Material 
Two hundred and fifty-three Polish postmeno  -
pausal women with osteopenia or osteoporosis
independently of vertebral fractures and 132
postmenopausal women with normal BMD were
included in this study, all patients living in Poznan.
The research was carried out from August 2007 to
July 2008. We obtained written consent of the
patient to carry out these examinations. The
inclusion criteria were those aged 50-66 years who
were recruited from outpatients in the Menopause
and Osteoporosis Outpatient in Poznan and who
had reduced BMD compared to normal subjects,
independently of vertebral fractures. According to
the World Health Organization (WHO) [19]
definition, subjects were classified as having
osteoporosis if they had a T-score < –2.5 SD,
osteopenia if –2.5 < T-score < –1.0 SD, and normal
BMD if T-score was > –1.0 SD in at least one of the
measured areas (either the lumbar spine, or
femoral, or both). In our study BMD measured in
the lumbar spine (T-score) was the basis for the
group classification. Subjects with secondary
osteoporosis, metabolic bone disease, malignant
bone metastasis, endocrine, gastrointestinal,
rheumatological or haematological disorders,
hypogonadal states, osteogenesis imperfect,
glucocorticoid treatment or different coexisting
illness, whose presence could influence the
assessment of QoL, were excluded from the study.
The control group included postmenopausal women
with normal BMD aged 50-66 years. They were also
recruited from the Menopause and Osteoporosis
Outpatient in Poznan, during consultation in this
outpatient. For the control group exclusion criteria
were the same as those used for women with
osteopenia and osteoporosis. 
Ethics
The study was approved by the Regional
Research Ethical Committee of the University of
Medicine in Poznan. 
Data collection and measurements
All patients were interviewed for data collection
on clinical and sociodemographic parameters: age
at menopause, marital status, school education, job
and workplace, previous non-vertebral fractures,
use of bisphosphonates, use of hormone therapy,
history of osteoporosis, smoking and drinking
alcohol.
Anthropometric data 
Weight and height were measured at the 
time of bone densitometry measurements. The478 Arch Med Sci 3, June / 2011
body mass index (BMI) was calculated as body
weight/height2 (kg/m2).
Bone mineral density measurements
Bone mineral density of the lumbar spine (L1-
L4) in the anterior-posterior projection was
measured in women by dual energy X-ray
absorptiometry (DXA). Bone mineral density was
assessed in the lumbar spine using a LUNAR device.
Vertebral morphometry
Among patients with osteopenia and osteo  -
porosis we assessed vertebral fractures from L1-L4
using the DXA method of vertebral fracture
assessment (VFA) according to the Genant criteria.
Vertebral deformity was defined when anterior,
middle, or posterior height loss was more than 20%.
Mild fractures were defined as 20-25% height loss,
and moderate fractures as more than 25% height
loss [20]. Vertebral fractures were assessed using
a Luna Prodigy Advance device.
Questionnaires
The European Foundation for Osteoporosis
QUALEFFO questionnaire was previously adapted
and translated from the original version into the
Polish version [18]. Therefore we did not adapt and
translate this questionnaire. We have permission
for using QUALEFFO-41 from The European
Foundation for Osteoporosis. The Polish version of
QUALEFFO was administered to all subjects. The
Polish version of QUALEFFO, like the original version,
consists of 41 questions divided into five domains:
pain, physical function, social function, general
health perception and mental function. In our study
the physical function domain was divided into:
activities of daily living (ADL), jobs around the house
and mobility. Individual domain scores and total
score can be evaluated. Domain scores were
calculated by summing the answer scores and
submitting the sum to a linear transformation to
a 100 scale, where 0 represents the best and 100
the worst QoL [18]. 
Additionally we used a second questionnaire,
WHOQOL-100. The Polish WHOQOL group adapted
and translated the WHOQOL-100 questionnaire
from the original version into the Polish version [10].
We have permission for using WHOQOL-100 from
the Polish WHOQOL group. WHOQOL-100 contains
the following domains: pain and discomfort,
activities of daily living, environment, mobility, social
function, general health perception and mental
function. Lower scores indicate better QoL [10]. After
a short interview, a specialist led the women to the
next research. The subjects completed the
questionnaire alone in a separate room. We
checked whether all questions had been answered. 
Statistical analysis 
The answers to each question in QUALEFFO-41
were scored from 1 to 5, except for social function;
questions 23, 25 were scored from 1 to 3 and
questions 24, 26, 27, 28 were scored from 1 to 4.
For questions 24, 29 the answer “not applicable”
and question 26 the answer “no cinema or
theatre within a reasonable distance” were not
scored. The scores of questions 33, 34, 35, 37, 39,
40 were reversed so that a low score indicates
better health and a high score indicates worse
health. Individual domain scores and total score
can be evaluated. Domain scores were calculated
by summing the answer scores and submitting
the sum to a linear transformation to a 100 scale.
The total score was computed by summing the
scores of all questions and submitting the sum
to a linear transformation to a 100 scale; 
0 represents the best and 100 the worst QoL [18].
Descriptive statistics of all variables are presented
as the percentage, mean and SD. Comparisons
between groups were assessed by one-way
analysis of variance (ANOVA) with post hoc tests
for parametric values or by Kruskal-Wallis test
and χ2 test for nonparametric values. 
The validity of the specific questionnaire was
studied: the score construction used multitrait
analyses: “floor effect” and “ceiling effect”,
convergent validity, discriminant validity. 
Convergent validity indicates the percentage of
question scores correlating with the domain score
better than 0.40. Discriminant validity indicates the
percentage of question scores correlating better
with their own domain score than with the scores
of other domains. 
The internal reliability of QUALEFFO-41 was
studied using Cronbach’s α coefficient. Minimum
values of greater than or equal to 0.70 have been
recommended for group [21]. In addition, the
reproducibility of the QUALEFFO-41 scales was
assessed using Pearson’s correlation coefficient
among the same patients, who returned for
a follow-up visit after 4 weeks. The capacity of
questions to discriminate between women with
reduced BMD and normal subjects was assessed
by conditional logistic regression to derive an odds
ratio with 95% confidence intervals. The concurrent
validity, which is a measure of correlation between
similar domains, was assessed by correlation of
QUALEFFO-41 scores and WHOQOL-100 scores
regarded as standard. The discriminative power,
which measures the ability of the questionnaire to
discriminate between patients with reduced BMD
and patients with or without vertebral deformities,
was assessed by clinical validity. 
Additionally, receiver operating characteristic
(ROC) curves were constructed to assess the ability
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of the QUALEFFO-41 individual score domain and
total score to discriminate between patients with
osteopenia and osteoporosis from subjects with
normal BMD. The limit of significance was set at 
p < 0.05 for all analyses. All statistical analyses were
carried out using SPSS for Windows version 14.
Results
Sociodemographic and clinical results
The total study sample consisted of 385 indi  -
viduals. Table I shows demographic, clinical and
densitometric data of patients grouped according
to the WHO definition [19]. A significant difference
(p < 0.001) was found among the three groups for
age, BMI, previous non-vertebral fractures, paid
work, T-score and BMD. No statistically significant
differences were observed between the groups for
age at menopause, level of education, marital
situation, use of hormone therapy and smoking.
Table II shows risk factors in subjects.
Among patients with osteopenia and osteo  porosis
we assessed vertebral fractures from L-1-L-4 using
the DXA method of vertebral fracture assessment
(VFA) according to the Genant criteria [20]. Only
8.9% of patients with osteopenia and 21.2% of
patients with osteoporosis had mild vertebral
deformities and 3 women had moderate vertebral
deformities.
Evaluation of psychometric properties
Score construction
Table III shows the results of the multitrait
analysis of the QUALEFFO scale grouped according
to the domains: pain, physical function (activities
of daily living, jobs, mobility), social function, general
health perception, and mental function. The “floor
Parameters, number Normal subjects Osteopenic patients Osteoporotic patients Value of p
(T-score > –1.0) 132 (–2.5 < T-score ≤ –1.0) 168 (T-score ≤ –2.5) 85
Age (mean years, SD) [years] 55.5 (5.1) 57.8 (4.8) 59.9 (5.2) < 0.001
Body mass index (BMI)  26.0 (3.9) 24.7 (4.1) 22.3 (3.1) < 0.001
[kg/m2] (mean, SD)
Age at menopause  49.2 (3.5) 48.5 (5.2) 49.7 (4.5) 0.134 
(mean years, SD)
Education (%) 0.120b
Basic 1.5 4.8 2.4
Work-related 12.9 10.1 11.8
Higher 62.1 46.4 57.6
Academic 23.5 38.7 28.2
Marital situation (%)
Married 59.1 62.5 62.5 0.861a
Widowed 14.4 13.1 15.3 0.931a
Single 12.1 8.9 8.2 0.639a
Separated/divorced 14.4 15.5  11.8 0.751a
Paid work (%) 56.9  32.7  18.8 < 0.001a
T-score L1-L4 (mean, SD) –0.16 (0.80) –1.90 (0.53) –3.11 (0.65) < 0.001
BMD L1-L4 [g/cm2] 1.10 (0.11) 0.91 (0.13) 0.8 (0.08) < 0.001
Hormone therapy 34.8 47.0 40.0 0.350a
Bisphosphonates – 22.6 70.6 –
Mild vertebral deformities  0 8.9 21.2 –
by morphometry (%)
Drinking alcohol (%) 0 0 0
Smoking (%)
Never 53 42.9 64.6 0.821a
Past 34.2 44.6 21.2 0.636a
Current 13.0 13.0 14.0 0.944a
p-value by one-way ANOVA, aby χ2 test, bby Kruskal-Wallis test
Table I. Sociodemographic and clinical characteristics of women according to group (n = 385)480 Arch Med Sci 3, June / 2011
effect” indicates the percentage of subjects with
the lowest possible domain score (for pain it was
22.8% of subjects, for jobs around the house
20.5%). The “ceiling effect” indicates the percentage
of subjects with the highest possible domain score
(for general health perception it was 3.4%, for pain
0.08% and for social function 0.03%). 
Convergent validity indicates the percentage of
question scores correlating with the domain score
better than 0.40. Only for ADL and mental function
were there not 100% of questions correlating with
the domain score better than 0.40. 
Discriminant validity is the percentage of
question scores correlating better with their own
domain score than with the scores of other
domains. Only for social function were there not
100% of question scores correlating better with
their own domain score than the scores of other
domains. 
Reliability
Table IV shows the QUALEFFO-41 results
summary of response rates, internal consistency,
prevalence of the lowest answer category and
discrimination ability of the QUALEFFO-41 questions.
The response rate shows the number of valid
responses for each question presented as the
median and range. The response rate for all
questions in all the domains of QUALEFFO-41 was
high. The internal consistency of the domains,
assessed by Cronbach’s α, was for the following
domains: pain 0.89, jobs around the house 0.88,
mobility 0.88, social function 0.73, general health
perception 0.79, mental function 0.79; and for ADL
was lower than for other domains: 0.66. 
The results of this study indicate a good
repeatability after 4 weeks of all domains of
QUALEFFO-41. Reproducibility ranged from 0.85
(ADL) to 0.94 (Pain). Total QUALEFFO reproducibility
was 0.96. 
The prevalence of the lowest answer category is
presented for osteopenic, osteoporosis and control
subjects according to the WHO definition. The odds
ratio represents the discrimination between
osteopenic, osteoporotic and control subjects.
Validity 
Clinical validity
Table V shows the mean (SD) for three
densitometry categories according to the WHO
definition in the seven domains of QUALEFFO-41.
A significant difference was found for all domains
at p < 0.001; only for pain was the significant
difference at the level p < 0.01 between normal
subjects and osteoporotic patients and for social
function between normal subjects, osteopenic
patients and osteoporotic patients (Table V).
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Risk factor Normal subjects  Osteopenic patients Osteoporotic patients Value of p
(T-score > –1.0) (–2.5 < T-score ≤ –1.0) (T-score ≤ –2.5)
N % N % N %
Previous fragility fracture 35 27 46 27 18 21 0.527
Parental history of fracture 26 20 69 40 32 38 0.004
Current tobacco smoking 17 13 21 13 12 14 0.972
BMI < 19 kg/m2 0 0 1 1 10 12 < 0.01
Table II. Risk factors in postmenopausal women with reduced bone mineral density and normal subjects
Domain  Floor Ceiling Convergent  Discriminant 
effect [%] effect [%] validity [%] validity [%]
Pain: back pain, sleep disturbance 22.8 0.8 100 100
ADL: dressing, bathing, toilet 15.8 0 75 100
Jobs around the house: cleaning, cooking, washing,  20.5 0 100 100
dishes, shopping
Mobility: standing up, bending, kneeling, stairs,  13.2 0 100 100
walking, body image
Social function: sport, gardening, hobby, friends 2.8 0.3 100 72
General health perception 1.6 3.4 100 100
Mental function: fatigue, depression, loneliness,  0 0 89 100
energy, cheerfulness, hope, fear
Table III. Score construction – results of the multitrait analysis of QUALEFFO-41 scale Arch Med Sci 3, June / 2011 481
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In Table VI results are reported which were
obtained for each domain and the total QUALEFFO
score by comparing osteopenic and osteoporotic
patients with or without vertebral deformities
assessed by morphometry. Among osteopenic
patients 15 were found with mild vertebral
deformities and among osteoporotic patients 
15 with mild vertebral deformities and 3 with
moderate vertebral deformities. A significant
difference was found between patients with and
without vertebral deformities for social function and
total score. Among osteopenic patients a significant
difference was also found for mental function and
general health perception (p < 0.001). A significant
difference was found between osteoporotic patients
with and without vertebral deformities for pain and
ADL (Table VI).
Concurrent validity
Table VII shows the correlation coefficient be  -
tween scores of the QUALEFFO-41 and WHOQOL-100
scales. The correlation was negative among all
domains excluding pain. QUALEFFO-41 scores
increase with worse functioning and quality of life,
while WHOQOL-100 scale scores increase with
improved functioning and quality of life. There was
a significant correlation among all the domains of
QUALEFFO-41 and the corresponding WHOQOL-100
scales (p < 0.001). 
avariable has constant value, ** < 0.001, according to WHO definition: normal subjects (T-score > –1.0), osteopenic patients (–2.5 < T-score  ≤ –1),
osteoporotic patients (T-score  ≤ 2.5)
Domain Response Internal  Test-retest Prevalence of lowest answer category Discrimination
(no. of rate  [%] consistency Pearson’s Normal Osteopenic Osteoporotic odds ratio
questions) Median Cronbach’s subjects [%] patients [%] patients [%] Median
(range) Median Median Median (range)
(range)( range)( range)
Pain (5) 100  0.89 0.94** 34 (32-55) 21 (20-60) 26 (25-44) 1.0 (0.3-1.4)
(80-100)
ADL (4) 100  0.66 0.85** 77 (24-95) 71 (18-93) 60 (5-93) 1.1 (0.1-2.0)
(0-100)
Jobs around  100 0.88 0.91** 65 (37-85) 45 (17-67) 40 (14-64) 1.1 (0.1-2.1)
the house (5) (71-100)
Mobility (8) 100a 0.88 0.89** 66 (42-91) 53 (27-79) 51 (15-67) 1.1 (0.0-4.9)
Social 100a 0.73 0.87** 42 (14-84) 24 (14-83) 24 (9-81) 1.0 (0.1-1.5)
function (7)
General 100a 0.79 0.88** 3 (2-9) 3 (3-5) 6 (6-8) 1.2 (0.0-1.7)
health 
perception (3)
Mental 100a 0.79 0.92** 27 (2-57) 14 (4-35) 13 (0-47) 1.1 (0.0-1.6)
function (9)
Table IV. Evaluation of 41 questions for QUALEFFO scale in the seven domains
Post hoc tests: *Dunnett T3, **Bonferroni
Domain of QUALEFFO  Normal subjects (1)  Osteopenic patients (2) Osteoporotic patients (3) Value of p
(number of items)( T - score > –1.0) (–2.5 < T-score ≤ –1) (T-score ≤ 2.5)
Mean (SD) Mean (SD) Mean (SD)
Pain (5) 30.2 (25.9) 34.9 (25.6) 42.1 (30.0) < 0.01 (1 : 3)*
ADL (4) 11.6 (12.2) 16.2 (14.5) 19.2 (12.5) < 0.001 (1 : 2.3)*
Jobs around the house (5) 13.9 (15.6) 24.6 (21.8) 27.7 (20.1) < 0.001 (1 : 2.3)*
Mobility (8) 13.4 (13.9) 23.0 (18.2) 23.4 (15.3) < 0.001 (1 : 2.3)*
Social function (7) 37.5 (18.2) 44.6 (21.2) 46.4 (22.3) < 0.01 (1 : 2.3)**
General health perception (3) 46.0 (19.6) 55.4 (20.6) 60.9 (24.3) < 0.001 (1 : 2.3)*
Mental function (9) 32.0 (15.2) 39.1 (15.8) 41.1 (13.8) < 0.001 (1 : 2.3)**
Total QUALEFFO score 20.5 (10.3) 26.7 (12.2) 28.9 (11.8) < 0.001 (1 : 2.3)*
Table V. Scores for QUALEFFO-41 domains and total QUALEFFO score in patients grouped according to WHO definition.
The scores were transformed to a 0-100 scale482 Arch Med Sci 3, June / 2011
Predictive validity
Table VIII shows that the calculated values are
under the curve for each domain and total score.
All values were between 0.58 and 0.68, which
implies a medium discrimination capacity.
Discussion
In 1992 the European Foundation for Osteo  -
porosis formed a working party to develop a specific
quality of life questionnaire (QUALEFFO) for patients
with vertebral fractures [18]. The first version of
QUALEFFO included 48 questions and six visual
analogue scales. Most questions were new, but two
were taken from the Mediterranean Osteoporosis
Study (MEDOS) Questionnaire [22], and the
European Vertebral Osteoporosis Study (EVOS) [23],
questionnaires. During evaluation of psychometric
properties of QUALEFFO, seven were removed from
further analysis because there was a low response
rate (less than 50%) to these questions. The 41
questions were grouped in the following five
domains: pain, physical function (activities of daily
living, jobs around the house and mobility), social
function, general health perception and mental
function.
The original QUALEFFO questionnaire is
considered as a common and widely used version
of the questionnaire in order to evaluate the quality
Grażyna Bączyk, Tomasz Opala, Paweł Kleka
Higher scores indicate poorer QoL
Domain of QUALEFFO Osteopenic patients Osteoporotic patients
Vertebral fractures Vertebral fractures
No (n = 153) Yes (n = 15) p No (n = 67) Yes (n = 18) p
Pain 33.4 (23.2) 35.5 (26.5) 0.628 38.8 (29.7) 54.4 (28.3) 0.044
ADL 15.0 (14.7) 19.3 (13.6) 0.089 17.4 (11.7) 25.7 (13.7) 0.012
Jobs around the house 22.4 (22.4) 30.7 (18.9) 0.028 27.0 (20.2) 30.3 (20.3) 0.545
Mobility 22.1 (18.6) 25.3 (16.9) 0.311 22.5 (13.4) 26.7 (21) 0.427
Social function 42.5 (20.5) 50.3 (22.1) 0.033 46.1 (22.5) 49.9 (25.8) 0.029
General health perception 52.0 (14.5) 64.3 (16.7) < 0.001 60.2 (23.4) 63.4 (28.2) 0.62
Mental function 36.4 (14.5) 46.0 (17.2) < 0.001 40.3 (14) 44.0 (12.7) 0.323
Total QUALEFFO score 25.4 (12.3) 30.3 (11.3) 0.02 28.0 (11.1) 34.3 (14.9) 0.022
Table VI. Scores for QUALEFFO-41 domains and total QUALEFFO score in osteopenic and osteoporotic patients grouped
according to the presence of vertebral deformities assessed by morphometry. The scores were transformed to 
a 0-100 scale and are presented as mean (SD)
aHigher scores indicate poorer QoL, bHigher scores indicate better QoL
Domain of QUALEFFOa Domain of WHO-100b Correlation coefficient Value of p
Pain Pain 0.609 <  0.001
Activities of daily living Activities of daily living –0.604 < 0.001
Jobs around the house Environment –0.25 < 0.001
Mobility Mobility –0.664 <  0.001
Social function Social function  –0.279 < 0.001
General health perception General health –0.493 < 0.001
Mental function Mental function –0.463 < 0.001
Table VII. Correlation coefficient between scores of QUALEFFO-41 and WHOQOL-100 scales
Area under the curve = 0.5, higher values indicate better
discrimination, higher values indicate better discrimination
Domain of QUALEFFO-41 QUALEFFO-41 Area (SE)
Pain 0.58 (0.03)
Activities of daily living 0.64 (0.03)
Jobs around the house 0.68 (0.03)
Mobility 0.68 (0.03)
Social function 0.61 (0.03)
General health perception 0.66 (0.03)
Mental function 0.64 (0.03)
Total QUALEFFO-41 score 0.67 (0.03)
Table VIII. Receiver operating characteristic (ROC)
curve analysis for QUALEFFO-41 domains and total
QUALEFFO scoreArch Med Sci 3, June / 2011 483
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of life in osteoporotic patients with vertebral
fractures. The results of evaluation of psychometric
properties of the original version of QUALEFFO are
adequate. The internal coherence within the various
domains is adequate without excessive redundancy,
as indicated by the analyses of Cronbach’s α.
QUALEFFO can discriminate between patients with
vertebral fractures and age- and sex-matched
control subjects, indicating worse QoL in patients
than in controls. In international clinical trials
QUALEFFO-41 was used to assess changes during
treatment in patients with vertebral fractures. In
the Multiple Outcomes of Raloxifene Evaluation
(MORE) study [24], QUALEFFO-41 was shown to be
able to discriminate satisfactorily between patients
with or without prevalent vertebral fractures. In
osteoporosis low BMD is asymptomatic and
patients with or without low-grade fractures may
be unaware of their condition. Patients with
reduced BMD could have decreased QoL; con  -
tributing to it is their fear of falling or of future
fractures [25-6]. 
In the present study QUALEFFO-41 was
administered to patients with reduced BMD,
independently of vertebral fractures. The aim of the
research was to describe the psychometric
properties of the Polish version of QUALEFFO-41
among postmenopausal women with reduced BMD
compared to normal subjects, independently of
vertebral fractures. 
The aim of this study was also to answer
whether the Polish version of QUALEFFO-41 is able
to distinguish postmenopausal women with
reduced BMD from normal subjects, independently
of vertebral fractures. In addition, the study was to
assess the quality of life among postmenopausal
women with reduced BMD and compare the quality
of life among women with and without vertebral
deformities.
We classified our samples into three densitometry
categories, according to the WHO, as shown in 
Table I. The results of the score construction of the
multi-trait analysis (Table III) show floor and ceiling
effects, indicating the percentage of subjects with
the lowest or highest possible scores. The convergent
and discriminant validity concern the homogeneity
of questions in one domain. The convergent validity
indicates the percentage of question scores
correlating better than 0.40 with the domain score.
The discriminant validity indicates the percentage of
question scores correlating better with their domain
score than with the scores of other domains.
The results of the multitrait analysis indicate the
similarity between the score construction of the
Polish QUALEFFO-41 and the score results of the
original version. In our study reports the scores of
individual questions are better correlated with their
own domain than with other domains, reflecting
good discriminant validity. These findings are similar
to the original QUALEFFO [18].
Cronbach’s α coefficient reflecting the reliability
of the instrument for all domains was satisfactory.
For three domains, reliability coefficients were
higher than 0.80 and for three domains were higher
than 0.70. The activities of daily living exhibited
a lower value of 0.66. The results of this study
indicate good repeatability after 4 weeks of all
domains of QUALEFFO-41. These results (good
internal consistency and test-retest reliability) show
a similar tendency to the findings of the original
and another study [18, 28].
Results scores for domains of QUALEFFO-41 and
the score for total QUALEFFO-41 demonstrate
a significant difference (p < 0.001) among all
groups; only in the case of the pain domain was
there a significant difference at the level of p < 0.01
between normal subjects and osteoporotic patients,
and in the case of the social function domain
a difference was noted between normal subjects,
osteopenic patients and osteoporotic patients. The
results of this study also show a significant
impairment of QoL in patients with reduced BMD
compared to normal subjects, independently of
vertebral fractures. 
In several studies the QUALEFFO questionnaire
demonstrated the ability to discriminate between
patients with or without vertebral fractures [23]. The
results of this study also show that QUALEFFO-41 
is able to distinguish postmenopausal women with
reduced BMD from normal subjects, independently
of vertebral fractures. Other researchers have
reported that among subjects without vertebral
fractures, patients with osteoporosis have more
severe functional impairment than patients with
osteopenia [24]. Similar results have also been
presented by Romagnoli et al. [28]: a low BMD is
connected with a higher score for domains
exploring physical function, general health
perception and the total QUALEFFO score. 
There was a good correlation between
QUALEFFO-41 and WHOQOL-100, especially of the
pain, ADL and mobility domains. Social function and
jobs around the house were the domains with the
lowest correlation between both scales. These
differences indicate the importance of connected
generic and specific questionnaires for evaluation
of quality of life, especially in women with
osteoporosis. These results are similar to the results
of other studies using QUALEFFO and SF-36 [29]. 
Receiver operating characteristic curves analysis
demonstrated a good discriminating capacity of
individual domains and total QUALEFFO-41 score
for patients with reduced BMD. The values of the
area under the curve for each domain were from
0.58 (pain) to 0.68 (mobility). However, results of
the original version show that QUALEFFO is484 Arch Med Sci 3, June / 2011
successfully able to distinguish patients with
vertebral fractures from hospital controls [18]. 
To sum up our analysis, we can make some
important conclusions: 
1) the score construction of the Polish version of
QUALEFFO-41 is adequate. Scores of individual
questions are better correlated with their own
domain than with other domains, reflecting good
discriminant validity. Scores of individual
questions are better correlated with the domain
score, reflecting good convergent validity.
2) Cronbach’s α coefficient, reflecting the reliability
of the Polish version of QUALEFFO-41 for all
domains, is satisfactory. The results of test-retest
reliability indicate good repeatability.
3) validity evaluated in several ways (analysis of the
relationship between domain scores in
QUALEFFO-41 and WHOQOL-100, analysis of
means for three densitometry categories, analysis
by comparing osteopenic and osteoporotic
patients with or without vertebral deformities and
ROC curve analysis) demonstrates the good
property of this scale.
4) the Polish version of QUALEFFO-41 can be used
among postmenopausal women with reduced
BMD compared to normal subjects, indepen  -
dently of vertebral fractures. Carrying out in
Poland the first assessment of psychometric
properties of the Polish version of the QUALEFFO-
41 scale is a contribution to the development of
knowledge in the assessment of quality of life.
Satisfactory psychometric characteristics of the
QUALEFFO-41 scale allow the use of this scale to
evaluate the quality of life in postmenopausal
women with reduced BMD by other Polish re  -
searchers.
5) the factor which determines the poor quality of
life of postmenopausal women with reduced BMD
is a functional state, expressed by reduced BMD,
which limits physical activity and mobility, and
produces postural deformities, pain and mood
deterioration. 
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